These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 21276737)

  • 21. Eosinophilic granulocytes and interleukin-6 level in bronchoalveolar lavage fluid are associated with the development of obliterative bronchiolitis after lung transplantation.
    Scholma J; Slebos DJ; Boezen HM; van den Berg JW; van der Bij W; de Boer WJ; Koëter GH; Timens W; Kauffman HF; Postma DS
    Am J Respir Crit Care Med; 2000 Dec; 162(6):2221-5. PubMed ID: 11112142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic lung allograft dysfunction after lung transplantation: the moving target.
    Sato M
    Gen Thorac Cardiovasc Surg; 2013 Feb; 61(2):67-78. PubMed ID: 23138970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibroproliferation in chronic lung allograft dysfunction: Association of mesenchymal cells in bronchoalveolar lavage with phenotypes and survival.
    Combs MP; Xia M; Wheeler DS; Belloli EA; Walker NM; Braeuer RR; Lyu DM; Murray S; Lama VN
    J Heart Lung Transplant; 2020 Aug; 39(8):815-823. PubMed ID: 32360292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term azithromycin use for treatment of bronchiolitis obliterans syndrome in lung transplant recipients.
    Shitrit D; Bendayan D; Gidon S; Saute M; Bakal I; Kramer MR
    J Heart Lung Transplant; 2005 Sep; 24(9):1440-3. PubMed ID: 16143268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bile acids aspiration reduces survival in lung transplant recipients with BOS despite azithromycin.
    Mertens V; Blondeau K; Van Oudenhove L; Vanaudenaerde B; Vos R; Farre R; Pauwels A; Verleden G; Van Raemdonck D; Sifrim D; Dupont LJ
    Am J Transplant; 2011 Feb; 11(2):329-35. PubMed ID: 21272237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Broncho-alveolar lavage matrix metalloproteases as a sensitive measure of bronchiolitis obliterans.
    Taghavi S; Krenn K; Jaksch P; Klepetko W; Aharinejad S
    Am J Transplant; 2005 Jun; 5(6):1548-52. PubMed ID: 15888067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Failure of IL-8 to assess early reperfusion injury following lung transplantation of cardiac death donor pigs.
    Lascano EC; Bertolotti A; Gómez CB; Ossés J; Negroni JA; Cuniberti L; Yannarelli GG; Molinari LE; Laguens R; Favaloro R
    Transpl Int; 2009 May; 22(5):574-82. PubMed ID: 19175556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential novel biomarkers for chronic lung allograft dysfunction and azithromycin responsive allograft dysfunction.
    Veraar C; Kliman J; Benazzo A; Oberndorfer F; Laggner M; Hacker P; Raunegger T; Janik S; Jaksch P; Klepetko W; Ankersmit HJ; Moser B
    Sci Rep; 2021 Mar; 11(1):6799. PubMed ID: 33762606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phenotyping established chronic lung allograft dysfunction predicts extracorporeal photopheresis response in lung transplant patients.
    Greer M; Dierich M; De Wall C; Suhling H; Rademacher J; Welte T; Haverich A; Warnecke G; Ivanyi P; Buchholz S; Gottlieb J; Fuehner T
    Am J Transplant; 2013 Apr; 13(4):911-918. PubMed ID: 23406373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bronchoalveolar lavage fluid characteristics in acute and chronic lung transplant rejection.
    Slebos DJ; Postma DS; Koëter GH; Van Der Bij W; Boezen M; Kauffman HF
    J Heart Lung Transplant; 2004 May; 23(5):532-40. PubMed ID: 15135367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of azithromycin and tanomastat on experimental bronchiolitis obliterans.
    Krenn K; Gmeiner M; Paulus P; Sela N; Torres L; Zins K; Dekan G; Aharinejad S
    J Thorac Cardiovasc Surg; 2015 Apr; 149(4):1194-202. PubMed ID: 25595376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The contribution of airway ischemia and vascular remodelling to the pathophysiology of bronchiolitis obliterans syndrome and chronic lung allograft dysfunction.
    Snell GI; Westall GP
    Curr Opin Organ Transplant; 2010 Oct; 15(5):558-62. PubMed ID: 20693899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bronchoalveolar bile acid and inflammatory markers to identify high-risk lung transplant recipients with reflux and microaspiration.
    Zhang CYK; Ahmed M; Huszti E; Levy L; Hunter SE; Boonstra KM; Moshkelgosha S; Sage AT; Azad S; Zamel R; Ghany R; Yeung JC; Crespin OM; Frankel C; Budev M; Shah P; Reynolds JM; Snyder LD; Belperio JA; Singer LG; Weigt SS; Todd JL; Palmer SM; Keshavjee S; Martinu T;
    J Heart Lung Transplant; 2020 Sep; 39(9):934-944. PubMed ID: 32487471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bronchoalveolar lavage fluid proteome in bronchiolitis obliterans syndrome: possible role for surfactant protein A in disease onset.
    Meloni F; Salvini R; Bardoni AM; Passadore I; Solari N; Vitulo P; Oggionni T; Viganò M; Pozzi E; Fietta AM
    J Heart Lung Transplant; 2007 Nov; 26(11):1135-43. PubMed ID: 18022079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bile acid aspiration and the development of bronchiolitis obliterans after lung transplantation.
    D'Ovidio F; Mura M; Tsang M; Waddell TK; Hutcheon MA; Singer LG; Hadjiliadis D; Chaparro C; Gutierrez C; Pierre A; Darling G; Liu M; Keshavjee S
    J Thorac Cardiovasc Surg; 2005 May; 129(5):1144-52. PubMed ID: 15867792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Connective Tissue Growth Factor Is Overexpressed in Explant Lung Tissue and Broncho-Alveolar Lavage in Transplant-Related Pulmonary Fibrosis.
    Vanstapel A; Goldschmeding R; Broekhuizen R; Nguyen T; Sacreas A; Kaes J; Heigl T; Verleden SE; De Zutter A; Verleden G; Weynand B; Verbeken E; Ceulemans LJ; Van Raemdonck DE; Neyrinck AP; Schoemans HM; Vanaudenaerde BM; Vos R
    Front Immunol; 2021; 12():661761. PubMed ID: 34122421
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-Resolution CT Findings of Obstructive and Restrictive Phenotypes of Chronic Lung Allograft Dysfunction: More Than Just Bronchiolitis Obliterans Syndrome.
    Hota P; Dass C; Kumaran M; Simpson S
    AJR Am J Roentgenol; 2018 Jul; 211(1):W13-W21. PubMed ID: 29792746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Lung Microbiome Predicts Mortality and Response to Azithromycin in Lung Transplant Recipients with Chronic Rejection.
    Combs MP; Luth JE; Falkowski NR; Wheeler DS; Walker NM; Erb-Downward JR; Wakeam E; Sjoding MW; Dunlap DG; Admon AJ; Dickson RP; Lama VN
    Am J Respir Crit Care Med; 2024 Jun; 209(11):1360-1375. PubMed ID: 38271553
    [No Abstract]   [Full Text] [Related]  

  • 39. Lung volumes predict survival in patients with chronic lung allograft dysfunction.
    Kneidinger N; Milger K; Janitza S; Ceelen F; Leuschner G; Dinkel J; Königshoff M; Weig T; Schramm R; Winter H; Behr J; Neurohr C
    Eur Respir J; 2017 Apr; 49(4):. PubMed ID: 28404648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of bronchoalveolar lavage neutrophilia in stable lung transplant recipients.
    Neurohr C; Huppmann P; Samweber B; Leuschner S; Zimmermann G; Leuchte H; Baumgartner R; Hatz R; Frey L; Ueberfuhr P; Bittmann I; Behr J;
    J Heart Lung Transplant; 2009 May; 28(5):468-74. PubMed ID: 19416775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.